ORIC Pharmaceuticals Inc. (ORIC): H.C. Wainwright Sees 172% Price Potential!
Reading Time: 2 minutes
ORIC Pharmaceuticals Inc. (ORIC) is a biopharmaceutical company focused on therapies to overcome cancer resistance. The name ORIC stands for "Overcoming Resistance In Cancer." The focus is on resistant tumors that are insensitive to conventional therapies. The therapeutic approaches aim to break the mechanisms of tumor resistance and enhance the efficacy of existing cancer drugs. Two main candidates in clinical development are particularly noteworthy. ORIC-114 is being investigated in an EGFR/HER2 inhibitor program with brain penetration. The ErbB...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
